FSPHX vs. RYOIX

Last updated Jun 4, 2026

FSPHX (Fidelity® Select Health Care Portfolio) and RYOIX (Rydex Biotechnology Fund) are both Health & Biotech Equities funds. Over the past 10 years, FSPHX returned 8.41%/yr vs 8.43%/yr for RYOIX. Their correlation of 0.82 suggests significant overlap in exposure. FSPHX charges 0.69%/yr vs 1.36%/yr for RYOIX.

Performance

FSPHX vs. RYOIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity® Select Health Care Portfolio (FSPHX) and Rydex Biotechnology Fund (RYOIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FSPHX achieves a -5.41% return, which is significantly lower than RYOIX's 3.07% return. Both investments have delivered pretty close results over the past 10 years, with FSPHX having a 8.41% annualized return and RYOIX not far ahead at 8.43%.

FSPHX

• 1D: -1.81%
• 1M: -1.00%
• YTD: -5.41%
• 6M: -12.69%
• 1Y: 6.59%
• 3Y*: 3.11%
• 5Y*: 1.14%
• 10Y*: 8.41%

RYOIX

• 1D: -2.50%
• 1M: -0.87%
• YTD: 3.07%
• 6M: 1.44%
• 1Y: 37.64%
• 3Y*: 12.67%
• 5Y*: 4.98%
• 10Y*: 8.43%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FSPHX vs. RYOIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FSPHX Fidelity® Select Health Care Portfolio	-5.41%	9.36%	4.91%	4.13%	-12.82%	11.58%	24.57%	31.48%	7.15%	23.83%
RYOIX Rydex Biotechnology Fund	3.07%	30.62%	-0.95%	6.06%	-13.04%	2.05%	21.94%	30.69%	-8.94%	29.68%

Correlation

The correlation between FSPHX and RYOIX is 0.84, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.84
Correlation (3Y) Calculated over the trailing 3-year period	0.80
Correlation (5Y) Calculated over the trailing 5-year period	0.83
Correlation (10Y) Calculated over the trailing 10-year period	0.86
Correlation (All Time) Calculated using the full available price history since Jan 5, 1999	0.82

The correlation between FSPHX and RYOIX has been stable across timeframes, ranging from 0.80 to 0.86 - a consistent structural relationship.

Return for Risk

FSPHX vs. RYOIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FSPHX

FSPHX Risk / Return Rank: 5
FSPHX Sharpe Ratio Rank: 5
FSPHX Sortino Ratio Rank: 5
FSPHX Omega Ratio Rank: 5
FSPHX Calmar Ratio Rank: 4
FSPHX Martin Ratio Rank: 4

RYOIX

RYOIX Risk / Return Rank: 62
RYOIX Sharpe Ratio Rank: 47
RYOIX Sortino Ratio Rank: 48
RYOIX Omega Ratio Rank: 40
RYOIX Calmar Ratio Rank: 90
RYOIX Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FSPHX vs. RYOIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity® Select Health Care Portfolio (FSPHX) and Rydex Biotechnology Fund (RYOIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FSPHX	RYOIX	Difference
Sharpe ratio: Return per unit of total volatility	0.40	2.02	-1.63
Sortino ratio: Return per unit of downside risk	0.65	2.93	-2.28
Omega ratio: Gain probability vs. loss probability	1.08	1.34	-0.26
Calmar ratio: Return relative to maximum drawdown	0.38	4.63	-4.25
Martin ratio: Return relative to average drawdown	0.85	16.65	-15.80
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FSPHX vs. RYOIX - Sharpe Ratio Comparison

The current FSPHX Sharpe Ratio is 0.40, which is lower than the RYOIX Sharpe Ratio of 2.02. The chart below compares the historical Sharpe Ratios of FSPHX and RYOIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	FSPHX	RYOIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.40	2.02	-1.63
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.06	0.24	-0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.44	0.36	+0.08
Sharpe Ratio (All Time) Calculated using the full available price history	0.75	0.36	+0.39

Drawdowns

FSPHX vs. RYOIX - Drawdown Comparison

The maximum FSPHX drawdown since its inception was -44.45%, smaller than the maximum RYOIX drawdown of -74.43%. Use the drawdown chart below to compare losses from any high point for FSPHX and RYOIX.

Drawdown Indicators

	FSPHX	RYOIX	Difference
Max Drawdown Largest peak-to-trough decline	-44.45%	-74.43%	+29.98%
Max Drawdown (1Y) Largest decline over 1 year	-18.32%	-8.43%	-9.89%
Max Drawdown (3Y) Largest decline over 3 years	-18.32%	-23.47%	+5.15%
Max Drawdown (5Y) Largest decline over 5 years	-29.31%	-33.66%	+4.35%
Max Drawdown (10Y) Largest decline over 10 years	-29.31%	-33.66%	+4.35%
Current Drawdown Current decline from peak	-14.46%	-4.48%	-9.98%
Average Drawdown Average peak-to-trough decline	-9.83%	-27.64%	+17.81%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.20%	2.34%	+5.86%

Volatility

FSPHX vs. RYOIX - Volatility Comparison

The current volatility for Fidelity® Select Health Care Portfolio (FSPHX) is 5.10%, while Rydex Biotechnology Fund (RYOIX) has a volatility of 6.58%. This indicates that FSPHX experiences smaller price fluctuations and is considered to be less risky than RYOIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FSPHX	RYOIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.10%	6.58%	-1.48%
Volatility (6M) Calculated over the trailing 6-month period	14.42%	14.84%	-0.42%
Volatility (1Y) Calculated over the trailing 1-year period	17.61%	19.35%	-1.74%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.32%	21.22%	-2.90%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.02%	23.23%	-4.21%

FSPHX vs. RYOIX - Expense Ratio Comparison

FSPHX has a 0.69% expense ratio, which is lower than RYOIX's 1.36% expense ratio.

Dividends

FSPHX vs. RYOIX - Dividend Comparison

FSPHX's dividend yield for the trailing twelve months is around 12.88%, more than RYOIX's 12.19% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FSPHX Fidelity® Select Health Care Portfolio	12.88%	4.16%	10.77%	0.00%	2.13%	9.06%	11.29%	1.35%	9.02%	2.27%	0.18%	11.63%
RYOIX Rydex Biotechnology Fund	12.19%	12.57%	14.61%	0.00%	1.29%	19.39%	7.28%	8.58%	14.11%	5.38%	0.00%	1.45%

Frequently Asked Questions

Can I hold both FSPHX and RYOIX in my portfolio?

FSPHX and RYOIX have a correlation of 0.84, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FSPHX or RYOIX?

RYOIX has higher volatility (6.58%) compared to FSPHX (5.10%). In terms of maximum drawdown, FSPHX dropped -44.45% vs RYOIX's -74.43%.

Which has better risk-adjusted returns?

RYOIX currently has the higher Sharpe Ratio (2.02 vs 0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.